Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
5.82
+0.10 (1.75%)
Apr 29, 2026, 9:30 AM EDT - Market open
Akari Therapeutics, Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 7 | 13 | 32 | 18 | 35 | 71 | |
| Market Cap Growth | -76.75% | -59.03% | 83.11% | -49.58% | -51.00% | 0.31% | |
| Enterprise Value | 2 | 13 | 31 | 10 | 27 | 58 | |
| Last Close Price | 5.72 | 11.56 | 48.80 | 124.80 | 375.92 | 1200.00 | |
| PB Ratio | 0.23 | 0.47 | 1.45 | -77.02 | 19.53 | 12.85 | |
| P/TBV Ratio | - | - | - | - | 19.72 | 12.91 | |
| Debt / Equity Ratio | 0.03 | 0.03 | 0.15 | - | - | - | |
| Net Debt / Equity Ratio | -0.16 | -0.16 | 0.03 | 16.79 | -7.40 | -1.68 | |
| Net Debt / EBITDA Ratio | 0.37 | 0.37 | -0.04 | 0.23 | 0.57 | 0.54 | |
| Net Debt / FCF Ratio | 0.42 | 0.42 | -0.05 | 0.23 | 0.62 | 0.50 | |
| Quick Ratio | 0.42 | 0.42 | 0.13 | 0.84 | 1.10 | 1.54 | |
| Current Ratio | 0.44 | 0.44 | 0.15 | 0.95 | 1.15 | 1.91 | |
| Return on Equity (ROE) | -68.43% | -68.43% | -179.92% | -1281.43% | -483.23% | -233.27% | |
| Return on Assets (ROA) | -15.36% | -15.36% | -37.89% | -115.51% | -113.26% | -81.96% | |
| Return on Capital Employed (ROCE) | -34.00% | -34.00% | -54.30% | 7338.90% | -1289.10% | -309.90% | |
| Earnings Yield | -267.22% | -130.73% | -61.28% | -56.74% | -50.73% | -24.40% | |
| FCF Yield | -163.25% | -79.87% | -38.87% | -93.17% | -61.47% | -26.40% | |
| Buyback Yield / Dilution | -181.85% | -181.85% | -144.03% | -56.79% | -45.46% | -35.87% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.